AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 11 min read$AVR

L1 Capital Pty Ltd sold $69K of AVR (indirect holdings)

L1 Capital Pty Ltd sold 7,800 indirectly-held shares of Anteris Technologies Global Corp. (AVR) at $8.83 on 2026-08-28.

Original reporting
SEC EDGAR · L1 Capital Pty Ltd
Published Sep 1, 2026, 10:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 10:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$AVR
Neutral
medium confidence
Mentioned
$AVR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVRNeutralLow
01

Why it matters

The disclosed sale provides transparency but is unlikely to affect AVR price materially.

02

Market read

Small insider sale; limited trading relevance.

03

What to watch

The sale was on an open market, not a pre‑arranged 10b5‑1 plan, which may indicate discretionary intent.

Relevance 3/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$AVRNeutralMedium confidence
Context

L1 Capital sold 7,800 AVR shares for $68,874, reducing its indirect holdings to 4,803,541 shares.

Expected impact

Minimal short‑term downward pressure, likely within normal volatility.

Evidence & confidence

Sale size (~$69K) is small relative to market cap; insider still holds a large position, so market impact is limited.

Market effects

Sector

No immediate sector-wide effect; AVR operates in medical device/diagnostics sector.

Regional

U.S. market only; no regional ripple.

Global

Limited to investors tracking AVR insider activity.

Counterpoint

What could challenge this read

If the insider is reducing exposure, it could signal concerns about near‑term performance.

Key entities

  • company
    Anteris Technologies Global Corp.

    Issuer of the AVR ticker.

  • insider
    L1 Capital Pty Ltd

    10% owner selling shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AVR insider trading history →

Related articles

AUG 12
$AVRMed

Anteris Advances DurAVR Toward Commercialization; PARADIGM Trial Expands U.S. Recruitment

Anteris Technologies Global Corp. (AVR) reported Q2 2026 results and said it secured U.S. Medicare reimbursement eligibility for PARADIGM Trial procedures. The company began U.S. recruitment, with first patients treated in May 2026, and said the trial is recruiting in the U.S., Denmark and the Netherlands. Net operating cash outflow was $20.8M; R&D expense was $23.4M.

rttnews.com5 min